We are announcing our new partnership with Menarini, a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide. Under the agreement, Menarini Hellas will commercialize Medis' OTC herbal medicine Ladiva in Greece and Cyprus under the brand name DIVAmenstral.
By adding DIVAmenstral to our portfolio, we will further strengthen our position in the women’s health segment in Greece and Cyprus. Together with Medis, we will offer an effective solution to relieve menstrual cramps for women who prefer natural rather than synthetic medicines,
said Anna Gourna, Business Unit Manager, Consumer Healthcare Division at Menarini Hellas.
Ladiva is an innovative product developed by Medis experts that brings a new treatment option to women. Keeping in mind that painful menstrual periods affect 85% of women between the ages of 15 and 45, we are proud to offer a natural and effective solution,
emphasized Maja Strnad Cestar, CEO at Medis.
For more information about Ladiva, please visit: https://www.medis.com/en/international-business/our-products/ladiva/